Southport Management, L.L.C. / BBIO
Southport Management, L.L.C.’s Bridgebio Pharma Inc Position
Does Southport Management, L.L.C. own Bridgebio Pharma Inc (BBIO)? Yes — 7.5K shares worth $573,675 (+2.00% of its 13F portfolio) as of Q4 2025, down from 10.0K shares the prior filed quarter.
Position Value
$573,675
Q4 2025
Shares
7.5K
% of Portfolio
+2.00%
Quarters Held
13
currently held
Position History BBIO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 7.5K | $573,675 | +2.00% |
| Q3 2025 | 10.0K | $519,400 | +2.14% |
| Q2 2025 | 15.0K | $647,700 | +3.16% |
| Q1 2025 | 15.0K | $518,550 | +2.24% |
| Q4 2024 | 15.0K | $411,600 | +1.49% |
| Q3 2024 | 15.0K | $381,900 | +1.42% |
| Q2 2024 | 15.0K | $379,950 | +1.70% |
| Q1 2024 | 15.0K | $463,800 | +1.71% |
| Q4 2023 | 15.0K | $605,550 | +2.61% |
| Q3 2023 | 15.0K | $395,550 | +2.15% |
| Q2 2023 | 15.0K | $258,000 | +1.41% |
| Q2 2021 | 12.0K | $732M | +2.47% |
| Q1 2021 | 12.0K | $739M | +2.74% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Southport Management, L.L.C.’s full portfolio or all institutional holders of BBIO.